The over-the-counter medical application is intended for individuals aged 18 years and older who have not been previously diagnosed with sleep apnea.

Atovaquone Oral Suspension is a quinone antimicrobial drug indicated for prevention and treatment of Pneumocystis jiroveci pneumonia in adults and children 13 years of age and older who cannot ...

HealthDay News — There are discrepancies between preferred and actual sources of contraceptive information for US adolescents and young adults (AYA), according to a research letter published online ...

Reduced risk for Alzheimer disease, vascular dementia, and Parkinson disease seen with SGLT2i use in type 2 diabetes.

Safety profile similar to other trials, with six in 10 sustaining medication overuse headache remission over six months ...

The Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) to Vanda Pharmaceuticals regarding the New Drug Application (NDA) for tradipitant for the treatment of gastroparesis.

HealthDay News — The demand for psilocybin-assisted therapy (PSIL-AT) for major depressive disorder (MDD) and treatment-resistant depression (TRD) varies from 24 to 62 percent depending on the ...

Following an inspection by the FDA, it was revealed that there was significant microbial contamination in 1 lot of SnoreStop Nasal Spray.